188 related articles for article (PubMed ID: 26577506)
41. Women's Health Initiative estrogen plus progestin clinical trial: a study that does not allow establishing relevant clinical risks.
Aedo S; Cavada G; Blümel JE; Chedraui P; Fica J; Barriga P; Brantes S; Irribarra C; Vallejo M; Campodónico Í
Menopause; 2015 Dec; 22(12):1317-22. PubMed ID: 25968833
[TBL] [Abstract][Full Text] [Related]
42. Effects of Hormone Therapy on Intraocular Pressure: The Women's Health Initiative-Sight Exam Study.
Vajaranant TS; Maki PM; Pasquale LR; Lee A; Kim H; Haan MN
Am J Ophthalmol; 2016 May; 165():115-24. PubMed ID: 26940165
[TBL] [Abstract][Full Text] [Related]
43. Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative.
Hsia J; Criqui MH; Rodabough RJ; Langer RD; Resnick HE; Phillips LS; Allison M; Bonds DE; Masaki K; Caralis P; Kotchen JM;
Circulation; 2004 Feb; 109(5):620-6. PubMed ID: 14769684
[TBL] [Abstract][Full Text] [Related]
44. Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative hormone therapy trials.
Maalouf NM; Sato AH; Welch BJ; Howard BV; Cochrane BB; Sakhaee K; Robbins JA
Arch Intern Med; 2010 Oct; 170(18):1678-85. PubMed ID: 20937929
[TBL] [Abstract][Full Text] [Related]
45. Menopausal Hormone Therapy and Risks of First Hospitalized Heart Failure and its Subtypes During the Intervention and Extended Postintervention Follow-up of the Women's Health Initiative Randomized Trials.
Liu L; Klein L; Eaton C; Panjrath G; Martin LW; Chae CU; Greenland P; Lloyd-Jones DM; Wactawski-Wende J; Manson JE
J Card Fail; 2020 Jan; 26(1):2-12. PubMed ID: 31536806
[TBL] [Abstract][Full Text] [Related]
46. Hormone therapy and physical function change among older women in the Women's Health Initiative: a randomized controlled trial.
Michael YL; Gold R; Manson JE; Keast EM; Cochrane BB; Woods NF; Brzyski RG; McNeeley SG; Wallace RB
Menopause; 2010 Mar; 17(2):295-302. PubMed ID: 19858764
[TBL] [Abstract][Full Text] [Related]
47. Ambient particulate matter air pollution and venous thromboembolism in the Women's Health Initiative Hormone Therapy trials.
Shih RA; Griffin BA; Salkowski N; Jewell A; Eibner C; Bird CE; Liao D; Cushman M; Margolis HG; Eaton CB; Whitsel EA
Environ Health Perspect; 2011 Mar; 119(3):326-31. PubMed ID: 21036692
[TBL] [Abstract][Full Text] [Related]
48. Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.
Chlebowski RT; Anderson GL; Aragaki AK; Prentice R
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26546117
[TBL] [Abstract][Full Text] [Related]
49. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
Hulley S; Furberg C; Barrett-Connor E; Cauley J; Grady D; Haskell W; Knopp R; Lowery M; Satterfield S; Schrott H; Vittinghoff E; Hunninghake D;
JAMA; 2002 Jul; 288(1):58-66. PubMed ID: 12090863
[TBL] [Abstract][Full Text] [Related]
50. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
Anderson GL; Limacher M; Assaf AR; Bassford T; Beresford SA; Black H; Bonds D; Brunner R; Brzyski R; Caan B; Chlebowski R; Curb D; Gass M; Hays J; Heiss G; Hendrix S; Howard BV; Hsia J; Hubbell A; Jackson R; Johnson KC; Judd H; Kotchen JM; Kuller L; LaCroix AZ; Lane D; Langer RD; Lasser N; Lewis CE; Manson J; Margolis K; Ockene J; O'Sullivan MJ; Phillips L; Prentice RL; Ritenbaugh C; Robbins J; Rossouw JE; Sarto G; Stefanick ML; Van Horn L; Wactawski-Wende J; Wallace R; Wassertheil-Smoller S;
JAMA; 2004 Apr; 291(14):1701-12. PubMed ID: 15082697
[TBL] [Abstract][Full Text] [Related]
51. Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.
Rossouw JE; Manson JE; Kaunitz AM; Anderson GL
Obstet Gynecol; 2013 Jan; 121(1):172-6. PubMed ID: 23262943
[TBL] [Abstract][Full Text] [Related]
52. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
Prentice RL; Langer RD; Stefanick ML; Howard BV; Pettinger M; Anderson GL; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
Am J Epidemiol; 2006 Apr; 163(7):589-99. PubMed ID: 16484450
[TBL] [Abstract][Full Text] [Related]
53. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.
Shlipak MG; Simon JA; Vittinghoff E; Lin F; Barrett-Connor E; Knopp RH; Levy RI; Hulley SB
JAMA; 2000 Apr; 283(14):1845-52. PubMed ID: 10770146
[TBL] [Abstract][Full Text] [Related]
54. Sex hormone levels and risk of breast cancer with estrogen plus progestin.
Farhat GN; Parimi N; Chlebowski RT; Manson JE; Anderson G; Huang AJ; Vittinghoff E; Lee JS; Lacroix AZ; Cauley JA; Jackson R; Grady D; Lane DS; Phillips L; Simon MS; Cummings SR
J Natl Cancer Inst; 2013 Oct; 105(19):1496-503. PubMed ID: 24041978
[TBL] [Abstract][Full Text] [Related]
55. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.
Lacey JV; Leitzmann MF; Chang SC; Mouw T; Hollenbeck AR; Schatzkin A; Brinton LA
Cancer; 2007 Apr; 109(7):1303-11. PubMed ID: 17315161
[TBL] [Abstract][Full Text] [Related]
56. Symptom experience after discontinuing use of estrogen plus progestin.
Ockene JK; Barad DH; Cochrane BB; Larson JC; Gass M; Wassertheil-Smoller S; Manson JE; Barnabei VM; Lane DS; Brzyski RG; Rosal MC; Wylie-Rosett J; Hays J
JAMA; 2005 Jul; 294(2):183-93. PubMed ID: 16014592
[TBL] [Abstract][Full Text] [Related]
57. Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials.
Wild RA; Wu C; Curb JD; Martin LW; Phillips L; Stefanick M; Trevisan M; Manson JE
Menopause; 2013 Mar; 20(3):254-60. PubMed ID: 23435021
[TBL] [Abstract][Full Text] [Related]
58. Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income.
Wei F; Miglioretti DL; Connelly MT; Andrade SE; Newton KM; Hartsfield CL; Chan KA; Buist DS
J Natl Cancer Inst Monogr; 2005; (35):106-12. PubMed ID: 16287895
[TBL] [Abstract][Full Text] [Related]
59. Venous thrombosis and conjugated equine estrogen in women without a uterus.
Curb JD; Prentice RL; Bray PF; Langer RD; Van Horn L; Barnabei VM; Bloch MJ; Cyr MG; Gass M; Lepine L; Rodabough RJ; Sidney S; Uwaifo GI; Rosendaal FR
Arch Intern Med; 2006 Apr; 166(7):772-80. PubMed ID: 16606815
[TBL] [Abstract][Full Text] [Related]
60. Reliable evidence from placebo-controlled, randomized, clinical trials for menopausal hormone therapy's influence on incidence and deaths from breast cancer.
Chlebowski RT; Anderson GL; Prentice RL; Rossouw JE; Aragaki AK; Manson JE
Climacteric; 2015 Jun; 18(3):336-8. PubMed ID: 25966858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
